Want to see HK:2576 full AI Analyst Report?
Zhejiang Taimei Medical Technology Co Ltd Class H (2576) Ratios
Zhejiang Taimei Medical Technology Co Ltd Class H Ratios
HK:2576's free cash flow for Q2 2026 was $-33.53M. For the 2026 fiscal year, HK:2576's free cash flow was decreased by $-1.24M and operating cash flow was $-32.29M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.47 | 5.05 | 3.71 | 4.24 | 4.55 |
| Quick Ratio | 4.47 | 5.05 | 3.71 | 4.24 | 4.55 |
| Cash Ratio | 1.91 | 1.09 | 1.45 | 1.70 | 1.94 |
| Solvency Ratio | -0.06 | -0.50 | -0.73 | -0.81 | -1.13 |
| Operating Cash Flow Ratio | -0.12 | -0.69 | -0.98 | -0.84 | -0.62 |
| Short-Term Operating Cash Flow Coverage | -0.82 | -20.15 | -25.91 | -9.25 | 0.00 |
| Net Current Asset Value | $ 1.10B | $ 1.13B | $ 923.63M | $ 1.22B | $ 1.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.02 | 0.02 | 0.04 | 0.04 |
| Debt-to-Equity Ratio | 0.05 | 0.03 | 0.03 | 0.06 | 0.05 |
| Debt-to-Capital Ratio | 0.05 | 0.03 | 0.03 | 0.06 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.39 | 1.37 | 1.48 | 1.39 | 1.28 |
| Debt Service Coverage Ratio | -0.59 | -16.47 | -20.22 | -9.52 | -162.57 |
| Interest Coverage Ratio | -75.79 | -347.25 | -277.14 | -165.16 | -186.65 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.11 | 0.06 | 0.05 | 0.15 | 0.14 |
| Net Debt to EBITDA | 19.74 | 1.61 | 1.61 | 1.61 | 1.37 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.44% | 40.81% | 31.23% | 33.76% | 35.09% |
| EBIT Margin | -9.73% | -39.31% | -61.93% | -76.45% | -102.30% |
| EBITDA Margin | -5.73% | -32.07% | -52.86% | -66.34% | -94.47% |
| Operating Profit Margin | -12.32% | -45.80% | -69.20% | -80.62% | -108.46% |
| Pretax Profit Margin | -9.89% | -39.45% | -62.18% | -76.94% | -102.88% |
| Net Profit Margin | -8.36% | -38.94% | -60.51% | -75.18% | -102.88% |
| Continuous Operations Profit Margin | -9.89% | -39.45% | -62.18% | -76.94% | -102.88% |
| Net Income Per EBT | 84.51% | 98.71% | 97.31% | 97.71% | 100.00% |
| EBT Per EBIT | 80.31% | 86.12% | 89.86% | 95.44% | 94.85% |
| Return on Assets (ROA) | -2.68% | -13.56% | -24.00% | -22.62% | -26.57% |
| Return on Equity (ROE) | -3.72% | -18.54% | -35.45% | -31.52% | -33.99% |
| Return on Capital Employed (ROCE) | -5.00% | -19.56% | -36.49% | -30.88% | -34.75% |
| Return on Invested Capital (ROIC) | -4.78% | -19.24% | -35.64% | -29.50% | -33.90% |
| Return on Tangible Assets | -2.78% | -14.07% | -25.40% | -23.67% | -28.19% |
| Earnings Yield | -2.08% | -9.47% | -7.42% | -9.07% | -11.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.48 | 2.94 | 3.22 | 3.36 | 3.83 |
| Payables Turnover | 2.76 | 3.26 | 5.57 | 7.56 | 7.06 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 22.35 | 14.71 | 13.88 | 6.47 | 4.24 |
| Asset Turnover | 0.32 | 0.35 | 0.40 | 0.30 | 0.26 |
| Working Capital Turnover Ratio | 0.43 | 0.51 | 0.51 | 0.44 | 0.00 |
| Cash Conversion Cycle | 14.86 | 12.33 | 47.98 | 60.26 | 43.71 |
| Days of Sales Outstanding | 147.17 | 124.17 | 113.47 | 108.54 | 95.40 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 132.31 | 111.85 | 65.49 | 48.28 | 51.69 |
| Operating Cycle | 147.17 | 124.17 | 113.47 | 108.54 | 95.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.07 | -0.36 | -0.63 | -0.59 | -0.39 |
| Free Cash Flow Per Share | -0.08 | -0.37 | -0.64 | -0.64 | -0.45 |
| Dividend Paid and CapEx Coverage Ratio | -10.45 | -32.73 | -37.06 | -11.66 | -6.71 |
| Capital Expenditure Coverage Ratio | -10.45 | -32.73 | -37.06 | -11.66 | -6.71 |
| Operating Cash Flow Coverage Ratio | -0.64 | -5.80 | -12.26 | -4.04 | -2.81 |
| Operating Cash Flow to Sales Ratio | -0.08 | -0.37 | -0.61 | -0.60 | -0.47 |
| Free Cash Flow Yield | -2.15% | -9.15% | -7.72% | -7.85% | -5.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -48.07 | -10.56 | -13.47 | -11.03 | -8.75 |
| Price-to-Sales (P/S) Ratio | 4.02 | 4.11 | 8.15 | 8.29 | 9.01 |
| Price-to-Book (P/B) Ratio | 1.79 | 1.96 | 4.78 | 3.48 | 2.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -46.47 | -10.93 | -12.95 | -12.74 | -16.80 |
| Price-to-Operating Cash Flow Ratio | -50.92 | -11.24 | -13.30 | -13.83 | -19.30 |
| Price-to-Earnings Growth (PEG) Ratio | 0.59 | 0.28 | 0.83 | 0.79 | 0.00 |
| Enterprise Value Multiple | -50.39 | -11.21 | -13.80 | -10.89 | -8.17 |
| Enterprise Value | 1.44B | 1.98B | 4.18B | 3.97B | 3.60B |
| EV to EBITDA | -50.39 | -11.21 | -13.80 | -10.89 | -8.17 |
| EV to Sales | 2.89 | 3.60 | 7.30 | 7.22 | 7.72 |
| EV to Free Cash Flow | -33.39 | -9.56 | -11.60 | -11.10 | -14.39 |
| EV to Operating Cash Flow | -36.59 | -9.83 | -11.91 | -12.05 | -16.54 |
| Tangible Book Value Per Share | 2.02 | 2.09 | 1.72 | 2.32 | 2.33 |
| Shareholders’ Equity Per Share | 1.99 | 2.05 | 1.75 | 2.34 | 2.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.89 | 0.98 | 1.02 | 0.98 | 0.83 |
| Net Income Per Share | -0.07 | -0.38 | -0.62 | -0.74 | -0.86 |
| Tax Burden | 0.85 | 0.99 | 0.97 | 0.98 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.15 | 0.16 | 0.30 | 0.43 | 0.48 |
| SG&A to Revenue | 0.39 | 0.69 | 0.42 | 0.08 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.23 | 0.02 | 0.16 | 0.29 |
| Income Quality | 0.78 | 0.93 | 0.92 | 0.78 | 0.45 |
Currency in CNY
